文献速递心外重症与机械循环支持

EUROMACS第四份报告:聚焦标准化结局比

The fourth report of the European Registry for Patients with Mechanical Circulatory Support (EUROMACS) of the European Association for Cardiothoracic Surgery: focus on standardized outcome ratios.
PubMed 文献 · Eur J Cardiothorac Surg · 2025-01-01

该报告基于EUROMACS注册数据库,纳入截至2024年8月所有植入耐久性机械循环支持的患者,分析其临床特征与结局,并用惩罚逻辑回归预测期望事件数以计算标准化结局比。结果显示多数中心表现符合预期,且标准化出血比与缺血性卒中比呈正相关。

要点

  • 30天死亡率、大出血和缺血性卒中概率分别为9.6%、12.6%和2.1%。
  • 各中心标准化死亡率比存在差异,范围从0到1.4。
  • 标准化出血比与缺血性卒中比呈正相关(Spearman r=0.56,P=0.008)。

核心结论

  • 多数纳入中心在考虑患者人口学与合并症后表现符合预期。
  • 标准化出血比与缺血性卒中比呈正相关,提示需通过质量改进项目持续监测不良事件。

研究设计与样本

  • 回顾性注册研究,纳入EUROMACS注册数据库中截至2024年8月所有植入耐久性机械循环支持的患者。
  • 共分析来自17个国家32个中心的6962例植入(6408例患者,457例接受重复植入)。
  • 使用惩罚逻辑回归预测期望事件数,计算标准化结局比(观察/期望),随访完整度<90%的中心被排除在标准化结局比评估之外。

主要发现

  • 患者中位年龄58岁,男性占83%,INTERMACS 1级占17%。
  • 30天死亡率、大出血和缺血性卒中概率分别为9.6%、12.6%和2.1%。
  • 标准化死亡率比在各中心间存在差异,范围从0(95%CI 0-0)到1.4(95%CI 1.2-1.7)。
  • 标准化出血结局比与标准化缺血性卒中比呈正相关(Spearman r=0.56,P=0.008)。

临床怎么用

  • 可利用标准化结局比评估各中心机械循环支持患者的结局表现,识别偏离预期的中心。
  • 应持续监测出血和缺血性卒中事件,并关注两者之间的相关性。

局限性

  • 随访完整度<90%的中心被排除在标准化结局比评估之外,可能影响结果的代表性。
  • 标准化结局比基于惩罚逻辑回归预测,未涵盖所有潜在混杂因素。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: This 4th report aimed to provide insights into patient characteristics, outcomes and standardized outcome ratios of patients implanted with durable Mechanical Circulatory Support across participating centres in the European Registry for Patients with Mechanical Circulatory Support (EUROMACS) registry. METHODS: All registered patients receiving durable mechanical circulatory support up to August 2024 were included. The expected number of events was predicted using penalized logistic regression. Standardized outcome ratios (Observed/Expected events) were presented in plots to assess 30-day and 1-year mortality, ischaemic stroke and major bleeding outcomes. Expected events were estimated using penalized logistic regression using demographics and comorbidities as predictors. Centres with <90% follow-up completeness were excluded from standardized outcome ratio assessment. RESULTS: Analysis included 6962 implants in 6408 patients (457 patients underwent repeated implants) registered in EUROMACS from 17 countries (32 centres) (median age: 58 years, 83% males, 17% Interagency Registry for Mechanically Assisted Circulatory Support class 1). Thirty-day mortality, major bleeding and ischaemic stroke probabilities were 9.6, 12.6% and 2.1%, respectively. Standardized mortality ratios showed variability between centres, ranging from 0 (95% CI 0-0) to 1.4 (95% CI 1.2-1.7). Higher standardized bleeding outcome ratios correlated with higher standardized ischaemic stroke ratio's (Spearman r: 0.56, P = 0.008). CONCLUSIONS: Most included centres perform as expected given the demographics and comorbidities of patients. A positive correlation was found between standardized bleeding and ischaemic stroke ratios, reflecting the need of continuously monitoring of adverse events by quality improvement programs.

来源:Eur J Cardiothorac Surg,查看原文。版权归原作者所有。

引用

  1. Veen KM, Ahmed M, Stark C, et al. The fourth report of the European Registry for Patients with Mechanical Circulatory Support (EUROMACS) of the European Association for Cardiothoracic Surgery: focus on standardized outcome ratios. Eur J Cardiothorac Surg. 2025. PMID: 39874447. doi:10.1093/ejcts/ezaf016

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。